Cargando…
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
BACKGROUND: There is a lack of information as to which molecular processes, present at diagnosis, favor tumour escape from standard-of-care treatments in cervical cancer (CC). RAIDs consortium (www.raids-fp7.eu), conducted a prospectively monitored trial, [BioRAIDs (NCT02428842)] with the objectives...
Ejemplares similares
-
Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
por: Scholl, Suzy, et al.
Publicado: (2020) -
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
por: Scholl, Suzy M, et al.
Publicado: (2020) -
The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures
por: Haury, Anne-Claire, et al.
Publicado: (2011) -
Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts
por: Ziouèche-Mottet, Amira, et al.
Publicado: (2014) -
New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020)